English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FATE
#3072
Fate Therapeutics, Inc.
1.48
+2.07%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+2.07%
Mudança mensal
+12.12%
Mudança em 6 meses
+28.70%
Mudança anual
+39.62%
Fechamento anterior
1.45
Open
1.48
Bid
Ask
Low
1.48
High
1.48
Volume
50
Financials
- Market Capitalization 176.12 M
- Employee 181
- Founded 2007
- CEO Scott Wolchko
- Website www.fatetherapeutics.com
- Headquarter California, United States
- FIGI BBG000QP35H2
- Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
176.12 M Market capitalization
Price to earnings ratio
-0.85
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—